Covered recipient · General Payments record
YOUSAF ALI
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$32,033.49
- Reported across 105 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $2,200.00 | 1 |
| Food and Beverage | $563.41 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $2,545.51 | 8 |
| GlaxoSmithKline, LLC. | $58.04 | 4 |
| ABBVIE INC. | $50.00 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $36.40 | 1 |
| GENZYME CORPORATION | $32.55 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $26.63 | 1 |
| PFIZER INC. | $14.28 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $50.00 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103204611 | CMS |
| Amgen Inc. | $26.67 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115418054 | CMS |
| Amgen Inc. | $51.86 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115418060 | CMS |
| Amgen Inc. | $36.33 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115418067 | CMS |
| Amgen Inc. | $2,200.00 | 11/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1115418079 | CMS |
| Amgen Inc. | $34.78 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115418047 | CMS |
| Amgen Inc. | $138.60 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115418084 | CMS |
| Amgen Inc. | $22.29 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115418091 | CMS |
| Amgen Inc. | $34.98 | 11/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115418073 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $26.63 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117834400 | CMS |
| GENZYME CORPORATION | $32.55 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139962687 | CMS |
| GlaxoSmithKline, LLC. | $15.70 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116360132 | CMS |
| GlaxoSmithKline, LLC. | $13.94 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116571841 | CMS |
| GlaxoSmithKline, LLC. | $13.48 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115775186 | CMS |
| GlaxoSmithKline, LLC. | $14.92 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116623529 | CMS |
| Novartis Pharmaceuticals Corporation | $36.40 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086755449 | CMS |
| PFIZER INC. | $14.28 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130924561 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.